Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950170-25-109198
Filing Date
2025-08-14
Accepted
2025-08-14 21:37:31
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 13240
2 EX-99.1 ck0000000000-ex99_1.pdf EX-99.1 104392
  Complete submission text file 0000950170-25-109198.txt   159097
Mailing Address 16000 DALLAS PARKWAY SUITE 800 DALLAS TX 75248
Business Address 16000 DALLAS PARKWAY SUITE 800 DALLAS TX 75248 214.866.0202
Anson Funds Management LP (Filed by) CIK: 0001491072 (see all company filings)

EIN.: 300134498 | State of Incorp.: TX | Fiscal Year End: 1231

Mailing Address 30 FLOOR, DICARA SILVER CENTER NO.29 JIEFANG EAST RD, JIANGGAN DISTRICT HANGZHOU F4 310000
Business Address 30 FLOOR, DICARA SILVER CENTER NO.29 JIEFANG EAST RD, JIANGGAN DISTRICT HANGZHOU F4 310000 8615968976786
Nano Labs Ltd (Subject) CIK: 0001872302 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-93953 | Film No.: 251222219
SIC: 3674 Semiconductors & Related Devices
(CF Office: 04 Manufacturing)